the Israeli Society of Gene Therapy

Home Page
Home Page About us President's letter The Board Bylaws Regulations Membership
Gene Therapy Course Links Contact us
Event Sponsors:

The Israeli Association for the Study of Diabetes (IASD)



Co-Event Sponsors:








Exhibit Sponsors:
latest news
» Prizes for best lecture and po...
Best lecture - 1500 NIS
Best 2 posters - 750 NIS each
» Human Gene Therapy
The conference's abstracts will appear In April 2010 on line. They will be published in the May issue of the journal.

      

 

  7th Annual Conference of The ISGCT

Sponsored by the Israeli Assosiation for the Study of Diabetes (IASD)

Wednesday, May 5, 2010


  Sheba Medical Center
at Tel Hashomer, Ramat-Gan, Israel
Sourasky Auditorium 

 
                                            

SCIENTIFIC PROGRAM

To download the program click here   

                                                

Invited Speakers

 

Reprogramming liver cells into insulin-producing cells by pancreatic transcription factors
Li-Jun Yang, University of Florida, Gainsville, FL, USA

 

Gene transfer to induce cellular reprogramming for the treatment of diabetes
Mark Kay, Stanford, CA, USA

 

Reprogramming into pancreatic beta cells  based on developmental cues, converting alpha to beta cells
Patrick Collombat, INSERM, Nice, France

 

AAV vectors for gene therapy of the brain in lysosomal storage diseases
Jean Michel Heard, Institute Pasteur, INSERM, Paris, France

 

Ex-vivo expansion of adult human pancreatic islet beta cells
Shimon Efrat, Tel-Aviv University, Tel-Aviv, Israel


Delineating the molecular mechanisms regulating chromatin protein dynamics in embryonic stem cells
Eran Meshorer, The Hebrew University, Jerusalem, Israel

 

hESC – from bench to patient 
Benjamin Reubinoff,  Hadassah University Hospital, Jerusalem, Israel

 


Differentiated mesenchymal stem cells rescue sciatic nerve injury in rats
Daniel Offen, Tel-Aviv University, Tel-Aviv, Israel & and Rabin Medical Center, Petach Tikva, Israel

 

 

Targeting CEACAM1 in adoptive TIL transfer in melanoma
Gal Markel, Sheba Medical Center, Ramat-Gan, Israel and Tel-Aviv University, Tel-Aviv, Israel

 


Identification and prospective isolation of novel human renal stem/progenitor populations from normal and cancerous kidney tissue
Benjamin Dekel, Sheba Medical Center, Ramat-Gan, Israel and Tel Aviv University, Tel-Aviv, Israel

 


Dynamic interactions between the nervous and immune systems with the microenvironment, regulate normal and leukemic human stem cells
Tsvee Lapidot, Weizmann Institute of Science, Rehovot, Israel

 

 

Engineering cell platforms for cardiovascular regeneration
Marcelle Machluf, Technion-IIT, Haifa, Israel

 

 

Clinical and future application of autologous multipotential mesenchymal stromal stem cells for the treatment of neurological diseases

Shimon Slavin, International Center for Cell Therapy and Cancer Immunotherapy (CTCI), Tel-Aviv, Israel
    

 

 

    

 

Prof.